Direct Inpatient Medical Costs of Operative Treatment of Periprosthetic Hip and Knee Infections Are Twofold Higher Than Those of Aseptic Revisions
- PMID: 33252589
- PMCID: PMC8327701
- DOI: 10.2106/JBJS.20.00550
Direct Inpatient Medical Costs of Operative Treatment of Periprosthetic Hip and Knee Infections Are Twofold Higher Than Those of Aseptic Revisions
Abstract
Background: Periprosthetic joint infections (PJIs) following total hip arthroplasty (THA) and total knee arthroplasty (TKA) are associated with substantial morbidity. A better understanding of the costs of PJI treatment can inform prevention, treatment, and reimbursement strategies. The purpose of the present study was to describe direct inpatient medical costs associated with the treatment of hip and knee PJI.
Methods: At a single tertiary care institution, 176 hips and 266 knees that underwent 2-stage revisions for the treatment of PJI from 2009 to 2015 were compared with 1,611 hips and 1,276 knees that underwent revisions for aseptic indications. In addition, 84 hips and 137 knees that underwent irrigation and debridement (I&D) with partial component exchange were compared with 39 hips and 138 knees that underwent partial component exchange for aseptic indications. Line-item details of services billed during hospitalization were retrieved, and standardized direct medical costs were calculated in 2018 inflation-adjusted dollars.
Results: The mean direct medical cost of 2-stage revision THA performed for the treatment of PJI was significantly higher than that of aseptic revision THA ($58,369 compared with $22,846, p < 0.001). Similarly, the cost of 2-stage revision TKA performed for the treatment of PJI was significantly higher than that of aseptic revision TKA ($56,900 compared with $24,630, p < 0.001). Even when the total costs of aseptic revisions were doubled for a representative comparison with 2-stage procedures, the costs of PJI procedures were 15% to 28% higher than those of the doubled costs of aseptic revisions (p < 0.001). The mean direct medical cost of I&D procedures for PJI was about twofold higher than of partial component exchange for aseptic indications.
Conclusions: The direct medical costs of operative treatment of PJI following THA and TKA are twofold higher than the costs of similar aseptic revisions. The high economic burden of PJI warrants efforts to reduce the incidence of PJI. Reimbursement schemes should account for the high costs of treating PJI in order to ensure sustainable patient care.
Level of evidence: Economic Level IV. See Instructions for Authors for a complete description of levels of evidence.
Copyright © 2020 by The Journal of Bone and Joint Surgery, Incorporated.
Conflict of interest statement
Disclosure: This research was supported by the National Institutes of Health (NIH) under grant P30AR76312. On the Disclosure of Potential Conflicts of Interest forms, which are provided with the online version of the article, one or more of the authors checked “yes” to indicate that the author had a relevant financial relationship in the biomedical arena outside the submitted work and “yes” to indicate that the author had a patent and/or copyright, planned, pending, or issued, broadly relevant to this work (http://links.lww.com/JBJS/G210).
Figures


Similar articles
-
Direct Hospital Costs per Case of Periprosthetic Hip and Knee Joint Infections in Europe - A Systematic Review.J Arthroplasty. 2024 Jul;39(7):1876-1881. doi: 10.1016/j.arth.2024.01.032. Epub 2024 Jan 23. J Arthroplasty. 2024. PMID: 38266688
-
Economic Analysis of 4221 Revisions Due to Periprosthetic Joint Infection in Poland.Ortop Traumatol Rehabil. 2017 Jan 26;19(1):33-44. doi: 10.5604/15093492.1235276. Ortop Traumatol Rehabil. 2017. PMID: 28436379
-
Estimation of two-year hospital costs of hip and knee periprosthetic joint infection treatments using activity-based costing.Bone Joint J. 2024 Oct 1;106-B(10):1084-1092. doi: 10.1302/0301-620X.106B10.BJJ-2024-0106.R1. Bone Joint J. 2024. PMID: 39348903
-
Comparative Epidemiology of Revision Arthroplasty: Failed THA Poses Greater Clinical and Economic Burdens Than Failed TKA.Clin Orthop Relat Res. 2015 Jun;473(6):2131-8. doi: 10.1007/s11999-014-4078-8. Epub 2014 Dec 3. Clin Orthop Relat Res. 2015. PMID: 25467789 Free PMC article.
-
Outcome of Revision Surgery for Infection After Total Knee Arthroplasty: Results of 3 Surgical Strategies.JBJS Rev. 2019 Jun;7(6):e4. doi: 10.2106/JBJS.RVW.18.00084. JBJS Rev. 2019. PMID: 31188156 Review.
Cited by
-
Non-inferiority and Safety of Increased Povidone-Iodine (Betadine) Concentration for Irrigation Following Primary Total Joint Arthroplasty (TJA).Cureus. 2024 Feb 2;16(2):e53453. doi: 10.7759/cureus.53453. eCollection 2024 Feb. Cureus. 2024. PMID: 38435161 Free PMC article.
-
Hospital Financial Burden of Surgical Procedures for Periprosthetic Total Hip Arthroplasty Infection.Arthroplast Today. 2025 Jan 8;31:101609. doi: 10.1016/j.artd.2024.101609. eCollection 2025 Feb. Arthroplast Today. 2025. PMID: 39886561 Free PMC article.
-
The health-economic burden of hip and knee periprosthetic joint infections in Europe : a comprehensive analysis following primary arthroplasty.Bone Jt Open. 2025 Mar 8;6(3):298-311. doi: 10.1302/2633-1462.63.BJO-2024-0225.R1. Bone Jt Open. 2025. PMID: 40054494 Free PMC article.
-
CAMKK2 is upregulated in primary human osteoarthritis and its inhibition protects against chondrocyte apoptosis.Osteoarthritis Cartilage. 2023 Jul;31(7):908-918. doi: 10.1016/j.joca.2023.02.072. Epub 2023 Feb 27. Osteoarthritis Cartilage. 2023. PMID: 36858195 Free PMC article.
-
A Reproducible Cartilage Impact Model to Generate Post-Traumatic Osteoarthritis in the Rabbit.J Vis Exp. 2023 Nov 21;(201):10.3791/64450. doi: 10.3791/64450. J Vis Exp. 2023. PMID: 38078617 Free PMC article.
References
-
- Hebert CK, et al., Cost of treating an infected total knee replacement. Clin Orthop Relat Res, 1996(331): p. 140–5. - PubMed
-
- Lavernia C, Lee DJ, and Hernandez VH, The increasing financial burden of knee revision surgery in the United States. Clin Orthop Relat Res, 2006. 446: p. 221–6. - PubMed
-
- Lavernia CJ, et al., Revision and primary hip and knee arthroplasty. A cost analysis. Clin Orthop Relat Res, 1995(311): p. 136–41. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials